Gulnur Guler
@gulnurguler
ID: 406976926
07-11-2011 13:12:10
145 Tweet
115 Takipçi
367 Takip Edilen
HUGE public service for #pathologists (especially trainees) by GIPS (GI Pathology Society) Free download links for #GIPath talks at DDW and CAPathologists meetings DDW: usgips.com/presentation-f… CAP: usgips.com/presentation-f… A must see for those who could not attend. @CArnold_GI Aatur Singhi, MD PhD
HER2 mutations in Invasive lobular carcinoma need to be tested especially in high grade tumors by Dr. Dillon at #CBCIV Timothy Craig Allen, MD, JD, FCAP Genevieve Crane, MD, PhD Pembe Oltulu, MD
BRAF is now among actionable genes in colorectal cancer. From bench to clinic, this long journey revealed many important biologic characteristics of BRAF mutations which may shed light on the future... #sciencematters Winship Cancer Institute of Emory University
Here are the slides for a very special #pathcast on peripheral nerve tumors this upcoming Tuesday 26th Nov. Actually you are lucky: there are 12 cool slides\cases to preview for this session! Emilio Madrigal, DO Rifat Mannan, MD #neuropath #bstpath digital.pathology.johnshopkins.edu/repos/2205
Want to identify NTRK rearranged CRC? If you test CRC for MSI & BRAFV600E->do NTRK IHC on MLH1/PMS2/BRAFV600E triple neg CRCs 5.3%(8/152) will be pos & have rearrangements Virtually never in other CRCs: 0.02%(1/4417) Now published Modern Pathology: nature.com/articles/s4137…
Incredible list compiled by Matt Xi Luo, MD Kudos Kamran Mirza MD PhD - کامران مرزا for the idea to do #VirtualPathMatch (tip of the hat to you sir!) 👏🏾👏🏾👏🏾
#EoCRC ✳️ Please join us for our multidisciplinary discussion of EoCRC on this Wednesday‼️ ✳️ We will be discussing from epidemiology to biology and nuances in the management of EoCRC ‼️ OncoAlert CRC Change The Colon Club COLONTOWN moffitt.org/media/18475/42…